thiethylperazine has been researched along with Labyrinth Diseases in 2 studies
Thiethylperazine: A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)
thiethylperazine : A member of the class of phenothiazines that is perazine substituted by a ethylsulfanyl group at position 2.
Labyrinth Diseases: Pathological processes of the inner ear (LABYRINTH) which contains the essential apparatus of hearing (COCHLEA) and balance (SEMICIRCULAR CANALS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Semczuk, B | 1 |
| Klonowski, S | 1 |
| Kossowski, S | 1 |
2 other studies available for thiethylperazine and Labyrinth Diseases
| Article | Year |
|---|---|
[Treatment of spontaneous and postoperative labyrinth disorders with Torecan].
Topics: Adult; Aged; Female; Humans; Labyrinth Diseases; Male; Meniere Disease; Middle Aged; Thiethylperazin | 1969 |
[Clinical studies on the use of torecan in ear diseases].
Topics: Adult; Female; Hearing Disorders; Humans; Labyrinth Diseases; Male; Meniere Disease; Middle Aged; Th | 1969 |